NSPR
InspireMD Inc
Halal Rating :
Last Price
$2.70
Last updated:
Market Cap
-
7D Change
1.89%
1 Year Change
-13.04%
Company Overview
Industries
Exchange
Next Earnings Date
InspireMD Inc. is a medical device company that develops and commercializes proprietary MicroNet® stent platform technology for the treatment of complex vascular and coronary diseases. The company's main product is CGuard™ EPS, an innovative embolic prevention system designed for carotid artery disease treatment.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $1.81m | $10.27m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $1.74m | $10.0m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $1.51m | $8.93m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate InspireMD Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.